BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23722183)

  • 1. Pericytes in kidney fibrosis.
    Ren S; Duffield JS
    Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):471-80. PubMed ID: 23722183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease.
    Kramann R; DiRocco DP; Humphreys BD
    J Pathol; 2013 Nov; 231(3):273-89. PubMed ID: 24006178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel insights into pericyte-myofibroblast transition and therapeutic targets in renal fibrosis.
    Chang FC; Chou YH; Chen YT; Lin SL
    J Formos Med Assoc; 2012 Nov; 111(11):589-98. PubMed ID: 23217594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of fibrosis: the role of the pericyte.
    Schrimpf C; Duffield JS
    Curr Opin Nephrol Hypertens; 2011 May; 20(3):297-305. PubMed ID: 21422927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of pericytes: recent insights into kidney fibrosis and microvascular rarefaction.
    Fligny C; Duffield JS
    Curr Opin Rheumatol; 2013 Jan; 25(1):78-86. PubMed ID: 23196325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role played by perivascular cells in kidney interstitial injury.
    Rojas A; Chang FC; Lin SL; Duffield JS
    Clin Nephrol; 2012 May; 77(5):400-8. PubMed ID: 22551886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis.
    Chen YT; Chang FC; Wu CF; Chou YH; Hsu HL; Chiang WC; Shen J; Chen YM; Wu KD; Tsai TJ; Duffield JS; Lin SL
    Kidney Int; 2011 Dec; 80(11):1170-81. PubMed ID: 21716259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1.
    Ren S; Johnson BG; Kida Y; Ip C; Davidson KC; Lin SL; Kobayashi A; Lang RA; Hadjantonakis AK; Moon RT; Duffield JS
    Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1440-5. PubMed ID: 23302695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pivotal role of pericytes in kidney fibrosis.
    Kida Y; Duffield JS
    Clin Exp Pharmacol Physiol; 2011 Jul; 38(7):467-73. PubMed ID: 21517936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The origin of renal fibroblasts/myofibroblasts and the signals that trigger fibrosis.
    Sun YB; Qu X; Caruana G; Li J
    Differentiation; 2016 Sep; 92(3):102-107. PubMed ID: 27262400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Origin and function of myofibroblasts in kidney fibrosis.
    LeBleu VS; Taduri G; O'Connell J; Teng Y; Cooke VG; Woda C; Sugimoto H; Kalluri R
    Nat Med; 2013 Aug; 19(8):1047-53. PubMed ID: 23817022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Origin of myofibroblasts and cellular events triggering fibrosis.
    Mack M; Yanagita M
    Kidney Int; 2015 Feb; 87(2):297-307. PubMed ID: 25162398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perivascular CD73
    Perry HM; Görldt N; Sung SJ; Huang L; Rudnicka KP; Encarnacion IM; Bajwa A; Tanaka S; Poudel N; Yao J; Rosin DL; Schrader J; Okusa MD
    Am J Physiol Renal Physiol; 2019 Sep; 317(3):F658-F669. PubMed ID: 31364375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis.
    Humphreys BD; Lin SL; Kobayashi A; Hudson TE; Nowlin BT; Bonventre JV; Valerius MT; McMahon AP; Duffield JS
    Am J Pathol; 2010 Jan; 176(1):85-97. PubMed ID: 20008127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Mechanism of the Pericyte-Myofibroblast Transition in Renal Interstitial Fibrosis: Core Fucosylation Regulation.
    Wang N; Deng Y; Liu A; Shen N; Wang W; Du X; Tang Q; Li S; Odeh Z; Wu T; Lin H
    Sci Rep; 2017 Dec; 7(1):16914. PubMed ID: 29209018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go?
    Gressner OA; Rizk MS; Kovalenko E; Weiskirchen R; Gressner AM
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1024-35. PubMed ID: 18505415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biology of the renal pericyte.
    Smith SW; Chand S; Savage CO
    Nephrol Dial Transplant; 2012 Jun; 27(6):2149-55. PubMed ID: 22555252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis.
    Campanholle G; Ligresti G; Gharib SA; Duffield JS
    Am J Physiol Cell Physiol; 2013 Apr; 304(7):C591-603. PubMed ID: 23325411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney.
    Lin SL; Kisseleva T; Brenner DA; Duffield JS
    Am J Pathol; 2008 Dec; 173(6):1617-27. PubMed ID: 19008372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney pericytes: a novel therapeutic target in interstitial fibrosis.
    Smith SW; Schrimpf C; Parekh DJ; Venkatachalam M; Duffield JS
    Histol Histopathol; 2012 Dec; 27(12):1503-14. PubMed ID: 23059881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.